ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,069.52
0.50%
Dow Jones
44,974.98
0.58%
US Dollar vs MXN
20.436
-0.40%
Brent Oil
76.075
0.20%
Bitcoin
105,484.01
1.68%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Ipsen SA (IPN) Cotización

Ipsen SA

Ipsen SA (IPN)

EU
118.80
0.30
(0.25%)
Cerrado 30 Enero 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
118.80
Postura de Compra
118.50
Postura de Venta
119.40
Volume Operado de la Acción
150,260
115.20 Rango del Día 119.50
99.70 Rango de 52 semanas 126.70
Capitalización de Mercado [m]
9.745B
Precio Anterior
118.50
Precio de Apertura
118.20
Hora
25
@
118.8
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
63,246
Acciones en circulación
82,029,421
Rendimiento del Dividendo
1.01%
Ratio Precio/Utilidad
15.12
Beneficio por acción (BPA)
7.86
turnover
3.37B
Beneficio neto
644.4M

Acerca de Ipsen SA

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.ipsen.com
Sede
Boulogne-billancourt, Hauts-de-seine, Fra
Fundado
-
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 118.50 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 126.70 €.

Ipsen currently has 82,029,421 shares in issue. The market capitalisation of Ipsen is 9.72 € billion. Ipsen has a price to earnings ratio (PE ratio) of 15.12.

IPN Últimas noticias

Más noticias

Ipsen - Décembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Décembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

07 Enero 2025
UK Regulatory

Ipsen - Bilan semestriel - 31 12 2024

Ipsen - Bilan semestriel - 31 12 2024 Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF Boulogne-Billancourt (France), le 7 janvier 2025 - Au titre du contrat de liquidité...

07 Enero 2025
UK Regulatory

Ipsen - December 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - December 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

07 Enero 2025
UK Regulatory

Ipsen - Half year statement - 2024 12 31

Ipsen - Half year statement - 2024 12 31 Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF Boulogne-Billancourt (France), January 7th, 2025 – Under the liquidity agreement...

07 Enero 2025
UK Regulatory

Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de...

09 Diciembre 2024
UK Regulatory

Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights...

09 Diciembre 2024
UK Regulatory

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology Ipsen secures exclusive global rights to develop, manufacture and...

03 Diciembre 2024
UK Regulatory

Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe thérapeutique en immuno-oncologie

Ipsen et Biomunex annoncent un accord de licence mondial exclusif pour un activateur de cellules MAIT, une nouvelle classe thérapeutique en immuno-oncologie Ipsen obtient les droits mondiaux...

03 Diciembre 2024
UK Regulatory

Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology

Ipsen secures exclusive global rights to develop, manufacture and commercialize BMX-502, a pre-clinical novel T cell engager (TCE) with first-in-class potentialBMX-502 is a bispecific antibody...

03 Diciembre 2024
GlobeNewswire Inc.

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS Ipsen presents 3 late-breaking presentations and 8 abstracts across...

18 Noviembre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.10.0842459983151118.7121.9115.261141119.3722901DE
47.87.02702702703111125.611162825119.4507267DE
129.38.49315068493109.5125.6105.363246112.78179374DE
261615.5642023346102.8125.6100.361663111.01139833DE
5210.810108126.799.769133111.19573489DE
15632.6637.915022057186.14130.78078682106.10630282DE
26051.977.578475336366.9130.734.29768590.14393322DE

IPN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ipsen?
El precio actual de las acciones de Ipsen es 118.80 €
¿Cuántas acciones de Ipsen están en circulación?
Ipsen tiene 82,029,421 acciones en circulación
¿Cuál es la capitalización de mercado de Ipsen?
La capitalización de mercado de Ipsen es EUR 9.72B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ipsen?
Ipsen ha negociado en un rango de 99.70 € a 126.70 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ipsen?
El ratio precio/beneficio de Ipsen es 15.12
¿Cuál es el ratio de efectivo a ventas de Ipsen?
El ratio de efectivo a ventas de Ipsen es 2.89
¿Cuál es la moneda de reporte de Ipsen?
Ipsen presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Ipsen?
El último ingresos anual de Ipsen es EUR 3.37B
¿Cuál es el último beneficio anual de Ipsen?
El último beneficio anual de Ipsen es EUR 644.4M
¿Cuál es la dirección registrada de Ipsen?
La dirección registrada de Ipsen es 65 QUAI GEORGES GORSE, BOULOGNE-BILLANCOURT, HAUTS-DE-SEINE, 92100
¿Cuál es la dirección del sitio web de Ipsen?
La dirección del sitio web de Ipsen es www.ipsen.com
¿En qué sector industrial opera Ipsen?
Ipsen opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BIODSBiosynex DS
0.0502 €
(80.58%)
96.34k
ALTROTronic s Microsystems
5.30 €
(35.20%)
5
MLWEYWeya
0.027 €
(35.00%)
99k
VACBSPierre & Vacances
0.0708 €
(24.21%)
46.14k
MCPGrupo Media Capital Sgps Sa
2.00 €
(23.46%)
1,000
MLGEQGentlemen S Equity SA
0.0115 €
(-47.73%)
6.2k
NICBSNicox SA
0.0183 €
(-30.68%)
140
AELISAelis Farma SA
3.76 €
(-21.67%)
33.01k
ALNEVNeovacs
0.32 €
(-17.40%)
21.49k
ALBOOBOOSTHEAT
0.035 €
(-16.27%)
43.42k
ATOAtos SE
0.0022 €
(4.76%)
1.58B
BCPBanco Comercial Portugues SA
0.5052 €
(-0.67%)
50M
ALNRGEnergisme SA
0.0041 €
(-6.82%)
29.28M
KPNKoninklijke KPN NV
3.554 €
(-1.88%)
12.28M
ALCYBCybergun
0.0001 €
(0.00%)
9.42M

Discusión

Ver feed completo
docsetc docsetc 2 minutos hace
More Art, no facts.
CBDW
DewDiligence DewDiligence 2 minutos hace
CAT 4Q24 CC transcript:

https://finance.yahoo.com/news/caterpillar-cat-q4-2024-earnings-181523050.html
CAT
oldstocks oldstocks 3 minutos hace
$AFFU .0004 Affluence Corp Subsidiary OneMind Technologies has been mentioned on LinkedIn with MTi
https://investorshub.advfn.com/uimage/uploads/2025/1/30/nkzkpOneMindLeap2025.jpg

Affluence Corp $AFFU is also working on completing the purchase of MTi Mingothings
https://
AFFU
The Great Pumpkin The Great Pumpkin 3 minutos hace
Stop thinking logically and adhere to the pumper's fairy tails in their fantasy land.

#scam
LWLG
i_like_bb_stock i_like_bb_stock 4 minutos hace
ADIA https://x.com/ADIA_Nutrition/status/1884967144070549977
ADIA
canthelpit canthelpit 4 minutos hace
RNVA No offence but **ASK*** and seeing in black and white with my own eyes on a legal filling that states "Rennova Health, Inc., has voting control of the Company at this moment in time" would solve it all ,,,,can you tell me where in any of the sec filings that i can find that ,,, i
RNVA
i_like_bb_stock i_like_bb_stock 4 minutos hace
https://x.com/ADIA_Nutrition/status/1884967144070549977
ADIA
le-bon ton-roule le-bon ton-roule 4 minutos hace
Thanks for the clarification, so I am used to IBAT using M.T. most of the time… Either way it's a substantial amount more than they advertise… IBAT normally in the past has referred to Lithium Chloride produced and more importantly it's now Lithium Carbonate at a dramatic increase in tonnage, might
IBATF
vlispxpert vlispxpert 4 minutos hace
that chart I just posted is weekly, JSPR has history of "weeks/months" of running, so one day doesn't make this trade...imo

https://schrts.co/AifhGVBH

last $4 to $31 took almost 4 months...1st $3 to $38 only took 3 weeks...if you're looking for monster in a day, this ai
JSPR
i_like_bb_stock i_like_bb_stock 4 minutos hace
ADIA https://x.com/ADIA_Nutrition/status/1884967144070549977
ADIA
georgie18 georgie18 4 minutos hace
Yes I see that...🥳
TANH
IanFromSI IanFromSI 5 minutos hace
If the deal is terminated without Crown Labs buying RVNC, then those who have not yet sold their shares will get whatever the market offers.

Worst case, given that Revance management has issued multiple going concern warnings, those still holding the shares may end up with zero doll
RVNC
NeoSunTzu NeoSunTzu 5 minutos hace
She (Dingle) bought bonds backed by pools of mortgages which is not the same as debt issued that is backed by the company. She would not be able to covert those to stock, common or preferred. If she needed the funds she could obviously sell them, then buy stock, but would likely have to report both
FNMA
packerfan9 packerfan9 5 minutos hace
More lies. So the company are the ones selling new shares to fill buys. Yet they say share buyback the opposite of what they are doing. Dilution never ends here.
CBDL
ExtremelyBullishZig ExtremelyBullishZig 5 minutos hace
$5.85 still in sight.
AVXL
glenn1919 glenn1919 5 minutos hace
REKR......SOBR.........MULN.................................https://stockcharts.com/h-sc/ui?s=REKR&p=D&yr=0&mn=3&dy=0&id=p11960084343
MULN REKR SOBR
docsetc docsetc 5 minutos hace
CBDW-AI: Poised to transform the future, selling shares for Adnexus Biotech on the sly, if they don't have to close down shop, which is public knowledge.
CBDW
jbsliverer jbsliverer 6 minutos hace
More than $6 Million in Support of Climate Journalism
January 28, 2025 Press Releases Climate Solutions Journalism & Media Local News
https://www.macfound.org/press/press-releases/more-than-6-million-in-support-of-climate-journalism

Grants support the growing field of c
packerfan9 packerfan9 6 minutos hace
Never ending dilution. The history of this is all there to see. Like shareholders before this r/s. To ignore it and buy. You will lose it all. Only ones selling shares this low. The company.
CBDL
Rattlershehe Rattlershehe 6 minutos hace
So a $2.50 price target that would give us 217 million market cap. A four dollar price target would give us 350 million market cap. I however, believe that we could be over five dollars by the end of this physical year
KRTL
eastunder eastunder 6 minutos hace
XYZ cpps 93.81

L64H67 JAT

https://finviz.com/chart.ashx?t=XYZ&ty=c&ta=1&p=d&s=l
XYZ
jog49 jog49 7 minutos hace
So says the manure factory. stink stack should be able to help you out.
FNMA
DewDiligence DewDiligence 7 minutos hace
If the deal goes through, shareholders who don't tender get the same payout as those who do tender, but it may take slightly longer to get paid.
RVNC
Jimmy Joe Jimmy Joe 7 minutos hace
More P&D lies!

Dude, you are obviously underwater at this point. Can't swim in waters when the ticker you bash 24/7/365 is making a transformational move~?

Advice, don't jump in water you can't swim in; you should never have BET against $DBMM. All of those hopes and dre
DBMM

Su Consulta Reciente

EU
IPN
Ipsen
BIT
UC915B
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios